-
1
-
-
0025347103
-
Antithyroid drugs and graves' disease: A prospective randomized evaluation of the efficacy of treatment duration
-
Allanic H, Fauchet R, Orgiazzi J e Coll: Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab 70: 675-679, 1990.
-
(1990)
J Clin Endocrinol Metab
, vol.70
, pp. 675-679
-
-
Allanic, H.1
Fauchet, R.2
Orgiazzi, J.3
-
2
-
-
0027018409
-
Is standard 555 MBq 131-I therapy of hyperthyroidism ablative?
-
Bertelsen J, Herskind AM, Sprogoe Jackobsen U e Coll: Is standard 555 MBq 131-I therapy of hyperthyroidism ablative? Thyroidology 4: 103-106, 1992.
-
(1992)
Thyroidology
, vol.4
, pp. 103-106
-
-
Bertelsen, J.1
Herskind, A.M.2
Sprogoe Jackobsen, U.3
-
3
-
-
0027435316
-
Optimized dose planning of radioiodine therapy of benign thyroidal disease
-
Bockisch A, Jamitzky T, Derwanz R e Coll: Optimized dose planning of radioiodine therapy of benign thyroidal disease. J Nucl Med 34: 1632-1641, 1993.
-
(1993)
J Nucl Med
, vol.34
, pp. 1632-1641
-
-
Bockisch, A.1
Jamitzky, T.2
Derwanz, R.3
-
4
-
-
0020410127
-
Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease
-
Bouma DJ, Kammer H, Greer M. Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease. J Clin Endocrinol Metab 55: 1138-1142, 1982.
-
(1982)
J Clin Endocrinol Metab
, vol.55
, pp. 1138-1142
-
-
Bouma, D.J.1
Kammer, H.2
Greer, M.3
-
5
-
-
0032779489
-
Optimized radioiodine therapy of Graves' disease: Analysis of the delivered dose and Ol other possibile factors affecting outcome
-
Catargi B, Leprat F, Guyot M e Coll: Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and Ol other possibile factors affecting outcome. Eur J Endocrinol 141: 117-121, 1999.
-
(1999)
Eur J Endocrinol
, vol.141
, pp. 117-121
-
-
Catargi, B.1
Leprat, F.2
Guyot, M.3
-
6
-
-
0032611751
-
Cost-effectiveness analysis: Radioiodine orantithyroid medication in primary treatment of immune hyperthyroidism
-
Dietlein M, Moka D, Dederichs B e Coll: Cost-effectiveness analysis: radioiodine orantithyroid medication in primary treatment of immune hyperthyroidism Nucl Med 38: 7-14, 1999.
-
(1999)
Nucl Med
, vol.38
, pp. 7-14
-
-
Dietlein, M.1
Moka, D.2
Dederichs, B.3
-
7
-
-
0028889977
-
Assessment ot female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma
-
Dottorini ME, Lomuscio G, Mazzucchelli Le Coll: Assessment ot female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 36: 21-27, 1995.
-
(1995)
J Nucl Med
, vol.36
, pp. 21-27
-
-
Dottorini, M.E.1
Lomuscio, G.2
Mazzucchelli, L.3
-
8
-
-
0342861689
-
Surgical treatment of hyperthyroidsm
-
Falk S (Ed), Lippincott-Raven, Philadelphia
-
Falk S: Surgical treatment of hyperthyroidsm. In: Falk S (Ed) Thyroid disease: endocrinology, surgery, nuclear medicine and radiotherapy, pag 319-340. Lippincott-Raven, Philadelphia, 1997.
-
Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine and Radiotherapy
, vol.1997
, pp. 319-340
-
-
Falk, S.1
-
9
-
-
0025824202
-
Iodine-131 treatment of hyperthyroidism: Current issues
-
Farrar JJ, Toft AD. Iodine-131 treatment of hyperthyroidism: current issues Clin Endocrinol 35: 207-212, 1994.
-
(1994)
Clin Endocrinol
, vol.35
, pp. 207-212
-
-
Farrar, J.J.1
Toft, A.D.2
-
10
-
-
0028960640
-
Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism
-
Franklyn JA, Daykin J, Holder R e Coll: Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. Q J Med 88: 175-180, 1995.
-
(1995)
Q J Med
, vol.88
, pp. 175-180
-
-
Franklyn, J.A.1
Daykin, J.2
Holder, R.3
-
11
-
-
0034093096
-
Therapeutic options in the management of toxic and non-toxic nodular goiter
-
Freitas JE. Therapeutic options in the management of toxic and non-toxic nodular goiter. Sem Nucl Med 2: 88-97, 2000.
-
(2000)
Sem Nucl Med
, vol.2
, pp. 88-97
-
-
Freitas, J.E.1
-
12
-
-
0033933561
-
Ipertiroidisino post-chirurgico: Ruolo diagnostico e terapeutico della medicina nucleare
-
Giovanella L, De Palma D, Ceriani L e Coll: Ipertiroidisino post-chirurgico: ruolo diagnostico e terapeutico della medicina nucleare. Radiol Med 99: 294-297, 2000.
-
(2000)
Radiol Med
, vol.99
, pp. 294-297
-
-
Giovanella, L.1
De Palma, D.2
Ceriani, L.3
-
13
-
-
0021857474
-
Management of hyperthyroidism in children and adolescents
-
Hamburger JI. Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metabo 60: 1019-1024, 1980.
-
(1980)
J Clin Endocrinol Metabo
, vol.60
, pp. 1019-1024
-
-
Hamburger, J.I.1
-
14
-
-
0022443691
-
Radioactive iodine for thyrotoxicosis
-
Hegedus L, Hansen JM. Radioactive iodine for thyrotoxicosis. Lancet 876: 339-340, 1986.
-
(1986)
Lancet
, vol.876
, pp. 339-340
-
-
Hegedus, L.1
Hansen, J.M.2
-
15
-
-
0026655515
-
Leukemia incidence after iodine-131 exposure
-
Hqall P, Boice JD jr, Berg G e Coll: Leukemia incidence after iodine-131 exposure. Lancet 340: 1-4, 1992.
-
(1992)
Lancet
, vol.340
, pp. 1-4
-
-
Hqall, P.1
Boice J.D., Jr.2
Berg, G.3
-
16
-
-
0000387731
-
The thyroid gland
-
Wilson JD, Foster DW, Kronenberg HM, Reed Larsen P (Eds), WB Saunders Company, Philadelphia
-
Reed Larsen P, Davies TF, Hay ID: The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, Reed Larsen P (Eds) Williams Textbook of Endocrinology, pag 389-515, WB Saunders Company, Philadelphia, 1998.
-
(1998)
Williams Textbook of Endocrinology
, pp. 389-515
-
-
Reed Larsen, P.1
Davies, T.F.2
Hay, I.D.3
-
17
-
-
0021180459
-
Successful treatment of solitary toxic thyroid adenomas with relatively low-dose iodine-131 with low prevalence of hypothyroidism
-
Ross DS, Ridgway EC, Daniels GH, Successful treatment of solitary toxic thyroid adenomas with relatively low-dose iodine-131 with low prevalence of hypothyroidism. Ann Intern Med 101: 488-490, 1984.
-
(1984)
Ann Intern Med
, vol.101
, pp. 488-490
-
-
Ross, D.S.1
Ridgway, E.C.2
Daniels, G.H.3
-
18
-
-
0033312610
-
Success rate of radioiodine therapy in Graves' disease: The influence of thyrostatic medication
-
Sabri O, Zimmy M, Schulz G e Coll: Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication. J Clin Endocrinol Metab 84: 1229-1233, 1999.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 1229-1233
-
-
Sabri, O.1
Zimmy, M.2
Schulz, G.3
-
19
-
-
0030119606
-
Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients
-
Schlumberger M, De Vathaire F, Ceccarelli C e Coll: Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 37: 606-612, 1996.
-
(1996)
J Nucl Med
, vol.37
, pp. 606-612
-
-
Schlumberger, M.1
De Vathaire, F.2
Ceccarelli, C.3
-
20
-
-
0343732220
-
Iodine-131 treatment of hyperthyroidsm
-
Falk S (Ed), Lippincott-Raven, Philadelphia
-
Sobel HS, Bramlet R. Iodine-131 treatment of hyperthyroidsm. In Falk S (Ed) Thyroid disease: endocrinology, surgery, nuclear medicine and radiotherapy, pag. 297-317. Lippincott-Raven, Philadelphia 1997.
-
(1997)
Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine and Radiotherapy
, pp. 297-317
-
-
Sobel, H.S.1
Bramlet, R.2
-
22
-
-
0027104454
-
Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: A comparisor with Graves' disease 340
-
van Soestberaen MJ, van der Vijver AC, Graafland AD e Coll: Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparisor with Graves' disease 340: Endocrinol Invest 15: 797-800, 1992.
-
(1992)
1-4J Endocrinol Invest
, vol.15
, pp. 797-800
-
-
Van Soestberaen, M.J.1
Van Der Vijver, A.C.2
Graafland, A.D.3
|